帕金森病动物模型中的肠道细菌组成:系统性审查和元分析
Joshua D Elford1, Elise J Heesbeen1, Nienke A van der Plaats1
1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
NPJ Parkinson's disease
|January 27, 2026
概括
帕金森病 (PD) 的动物模型与人类相比显示出不一致的肠道微生物组变化. 短链脂肪酸 (SCFA) 为PD研究提供了更可靠和可翻译的结果.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物组与帕金森病 (PD) 病原发生有关.
- 人类研究显示PD患者的肠道微生物群发生变化,但临床前模型的相关性尚不清楚.
研究的目的:
- 系统地审查和分析临床前帕金森病模型,评估肠道微生物群.
- 评估PD动物模型中肠道微生物组变化的一致性和人类相关性.
主要方法:
- 临床前PD研究的系统审查和贝叶斯规范化元分析.
- 纳入标准:评估运动功能和肠道微生物群的研究.
- 专注于细菌多样性,特定种类和短链脂肪酸 (SCFA).
主要成果:
- 在PD模型中一致观察到运动缺陷.
- 肠道细菌多样性和特定种群变化不一致,与人类PD数据不一致.
- 短链脂肪酸 (SCFA) 显示出可重现的变化和更好的可转化到人类发现.
- 基于慢性毒素的模型表现出更高的可重复性.
结论:
- 在临床前的PD模型中,肠道微生物组组成缺乏一致性和人类相关性.
- 短链脂肪酸 (SCFA) 代表了PD研究中更可靠和可翻译的结果指标.
- 提出了改善未来研究报告的建议.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


